Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story? - Université de Lorraine Access content directly
Journal Articles Journal of Crohn's and Colitis Year : 2021

Dates and versions

hal-04214604 , version 1 (22-09-2023)

Identifiers

Cite

Lucas Guillo, Laurent Peyrin-Biroulet, Edouard Louis. Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story?. Journal of Crohn's and Colitis, 2021, 15 (7), pp.1087-1088. ⟨10.1093/ecco-jcc/jjab006⟩. ⟨hal-04214604⟩
5 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More